Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S.

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...

The drug is still in the trial phase.

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher ...

The U.S. Food and Drug Administration issued two Emergency Use Authorizations for treating New World screwworm infestations in dogs and cats.

The FDA is planning to only ask for one pivotal clinical trial instead of the long standard of two trials for drug approval. The present FDA commissioner believes it carries the same statistical power ...

A powerful synthetic drug that has already caused overdose deaths in eastern Tennessee has now been detected in central ...